111 related articles for article (PubMed ID: 24299210)
1. Nur77 inhibits androgen-induced bladder cancer growth.
Wu J; Liu J; Jia R; Song H
Cancer Invest; 2013 Dec; 31(10):654-60. PubMed ID: 24299210
[TBL] [Abstract][Full Text] [Related]
2. Testicular steroidogenesis is locally regulated by androgen via suppression of Nur77.
Song CH; Gong EY; Park Js; Lee K
Biochem Biophys Res Commun; 2012 Jun; 422(2):327-32. PubMed ID: 22575506
[TBL] [Abstract][Full Text] [Related]
3. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
4. Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling.
Wu J; Sun H; Yang X; Sun X
Clin Transl Oncol; 2018 Oct; 20(10):1302-1313. PubMed ID: 29594945
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer.
Shiota M; Takeuchi A; Yokomizo A; Kashiwagi E; Tatsugami K; Kuroiwa K; Naito S
J Urol; 2012 Jul; 188(1):276-86. PubMed ID: 22608749
[TBL] [Abstract][Full Text] [Related]
6. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor.
Izumi K; Zheng Y; Li Y; Zaengle J; Miyamoto H
Int J Oncol; 2012 Nov; 41(5):1587-92. PubMed ID: 22922989
[TBL] [Abstract][Full Text] [Related]
8. Androgen activates β-catenin signaling in bladder cancer cells.
Li Y; Zheng Y; Izumi K; Ishiguro H; Ye B; Li F; Miyamoto H
Endocr Relat Cancer; 2013 Jun; 20(3):293-304. PubMed ID: 23447569
[TBL] [Abstract][Full Text] [Related]
9. The role of the androgen receptor in the development and progression of bladder cancer.
Li Y; Izumi K; Miyamoto H
Jpn J Clin Oncol; 2012 Jul; 42(7):569-77. PubMed ID: 22593639
[TBL] [Abstract][Full Text] [Related]
10. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
11. Cytosporone B is an agonist for nuclear orphan receptor Nur77.
Zhan Y; Du X; Chen H; Liu J; Zhao B; Huang D; Li G; Xu Q; Zhang M; Weimer BC; Chen D; Cheng Z; Zhang L; Li Q; Li S; Zheng Z; Song S; Huang Y; Ye Z; Su W; Lin SC; Shen Y; Wu Q
Nat Chem Biol; 2008 Sep; 4(9):548-56. PubMed ID: 18690216
[TBL] [Abstract][Full Text] [Related]
12. Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis.
Guan YF; Huang QL; Ai YL; Chen QT; Zhao WX; Wang XM; Wu Q; Chen HZ
Oncogene; 2020 Mar; 39(11):2408-2423. PubMed ID: 31959898
[TBL] [Abstract][Full Text] [Related]
13. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL
Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968
[TBL] [Abstract][Full Text] [Related]
14. Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth.
Cho SD; Lee SO; Chintharlapalli S; Abdelrahim M; Khan S; Yoon K; Kamat AM; Safe S
Mol Pharmacol; 2010 Mar; 77(3):396-404. PubMed ID: 20023005
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
Mashima T; Okabe S; Seimiya H
Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
[TBL] [Abstract][Full Text] [Related]
16. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
17. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
19. Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/Src association.
Migliaccio A; Castoria G; Auricchio F
Methods Mol Biol; 2011; 776():361-70. PubMed ID: 21796537
[TBL] [Abstract][Full Text] [Related]
20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
